Skip Navigation


Schizophrenia Bulletin Advance Access originally published online on September 12, 2008
Schizophrenia Bulletin 2008 34(6):1008-1011; doi:10.1093/schbul/sbn123
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
34/6/1008    most recent
sbn123v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Frank, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frank, M. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org.

Schizophrenia: A Computational Reinforcement Learning Perspective

Michael J. Frank1
Department of Psychology, Program in Neuroscience, University of Arizona, 1503 E University Boulevard, Tucson, AZ 85721

The first 150 words of the full text of this article appear below.


As one of the most complex neurocognitive disorders, schizophrenia (SZ) is a devastating condition for which the underlying sources are far from being fully understood. Indeed, it is likely that there are multiple etiologies to the disease and heterogeneity within the population. Moreover, it is impossible to understand from a purely mechanistic basis how a patient would come to believe so strongly in delusions as to, for example, gouge out his own eyes.

Nevertheless, science marches forward, and the last 30 years or so have produced a wealth of knowledge regarding some of the risk factors, genetics, pharmacology, cognitive deficits, and underlying neurobiology associated with the disease.1–4 In part because of the efficacy of antipsychotic treatments via dopamine D2 receptor blockade,5 the majority of this research focuses on dysfunctions of the dopaminergic system, in both frontal cortex and basal ganglia, thought to be related to negative . . . [Full Text of this Article]


    Funding
 
1 To whom correspondence should be addressed; tel: 520-626-4787, fax: 520-621-9306, e-mail: mfrank@u.arizona.edu.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Schizophr BullHome page
G. I. Elmer and N. Kafkafi
Drug Discovery in Psychiatric Illness: Mining for Gold
Schizophr Bull, March 18, 2009; (2009) sbn194v1.
[Abstract] [Full Text] [PDF]